Navigation Links
Children's National researcher receives ACCP Distinguished Investigator Award
Date:9/8/2008

The American College of Clinical Pharmacology (ACCP) has awarded John van den Anker, MD, PhD, director of Pediatric Clinical Pharmacology at Children's National Medical Center, its annual Distinguished Investigator Award.

Dr. van den Anker, a neonatologist by training, receives this award for "his sustained and prolific contributions to pediatric clinical pharmacology," according to the ACCP.

The Distinguished Investigator Award is given yearly and recognizes superior scientific expertise and accomplishments by a senior investigator, usually involving a distinct area of research in basic or clinical pharmacology for which the individual is internationally known.

Dr. van den Anker is the director of Pediatric Clinical Pharmacology at Children's National Medical Center, and also serves as associate director of Children's Research Institute's Center for Clinical and Community Research. He is professor of Pediatrics, Pharmacology, and Physiology at the George Washington University School of Medicine and Health Sciences, and holds the Evan and Cindy Jones Chair in Pediatric Clinical Pharmacology at Children's National. He has received several major awards from the National Institutes of Health and has published more than 150 peer reviewed papers in the field of neonatal and pediatric clinical pharmacology. He also served as the president of the European Society of Developmental, Perinatal, and Pediatric Pharmacology from 2006-2008.


'/>"/>

Contact: Jennifer Leischer
jleische@cnmc.org
202-476-4500
Children's National Medical Center
Source:Eurekalert

Page: 1

Related biology news :

1. Corporate Safe Specialists Launches International Sales Efforts
2. New chemical radar among national security innovations in ACS podcast
3. International team reveals first prognosticator of survival in aggressive cancer
4. White House announces 2007 National Medal of Science laureates
5. National security remedies among topics at surveillance confab
6. Duke Medicine physician-scientist receives National Medal of Science
7. National Research Council report on security at federally managed dams
8. Food, health get top billing at national chemistry meeting
9. Childrens national co-leads nationwide study of landmark sickle cell treatment
10. Story tips from the US Department of Energys Oak Ridge National Laboratory, August 2008
11. [video] Michael DePasquale, CEO of BIO-key International, Inc., Discusses Q2 2008 Revenue Growth on WallSt.nets 3-Minute Press Show
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2014)... 2014  Earlier this year Donald Spector , ... one of the most prolific inventors in the world, ... from Smartphones to third party agencies. Spector envisioned this ... of the earliest known patents in this area. Now ... military, child care, elder care and hospital applications. This ...
(Date:11/21/2014)... 20, 2014 C-Labs LLC, a leading provider ... Things (IoT), today announced the appointment of John ... Previously a strategic advisor to the firm, Mr. Traynor ... Traynor is based out of the C-Labs office in ... Chris Muench , Chief Executive Officer. ...
(Date:11/18/2014)... WASHINGTON , Nov. 18, 2014  The ... Security Industry Association today jointly announce the formation ... and release of its Identity and Biometric ... (Framework). The Framework received official support from BORDERPOL, ... governments to improve and provide expertise regarding border ...
Breaking Biology News(10 mins):Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 2Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 3Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 4C-Labs Names Former Microsoft and Bsquare Executive as Chief Operating Officer 2Identity Management, Document Authentication and Biometric Companies Form "The Airport Entry and Exit Working Group", Releasing the Framework to Help Guide the Department of Homeland Security and Congress Towards Solutions 2Identity Management, Document Authentication and Biometric Companies Form "The Airport Entry and Exit Working Group", Releasing the Framework to Help Guide the Department of Homeland Security and Congress Towards Solutions 3
... study shows that land-use policies in Peru have been ... that country. Scientists at the Carnegie Institutions Department of ... years of high-resolution satellite data covering most (79%) of ... published in the August 9, 2007, on-line edition of ...
... New Haven, Conn. It is not just whats in your ... difference between species at least in yeast according to ... Weve known for a while that the protein coding genes ... senior author Michael Snyder , the Cullman Professor of ...
... Today, researchers report for the first time that genetic ... only from the motherare directly linked to metabolic markers ... the role of mitochondrial genome variation in the pathogenesis ... Research ( www.genome.org ). According to the ...
Cached Biology News:Rain forest protection works in Peru 2Evolution is driven by gene regulation 2Scientists show that mitochondrial DNA variants are linked to risk factors for type 2 diabetes 2
(Date:11/26/2014)... 25, 2014 Whitehouse Laboratories is ... the Morris County (New Jersey) Chamber of Commerce ... leading business organization in the North Jersey area, ... engage some key clients in the pharmaceutical and ... geographic area. Membership enables Whitehouse Laboratories a higher ...
(Date:11/26/2014)... 2014 The Pittcon marketing department is ... and exposition mobile app, Pittcon 2015 ... the App Store for iOS and Android devices and ... before, during and after the event. It acts as ... companies, technical sessions, Conferee Networking sessions and short courses. ...
(Date:11/26/2014)... DE (PRWEB) November 26, 2014 ... Heroes recognition reception on December 5, 2014, in San ... meeting. The MPN Heroes event will honor clinicians, caregivers, ... field of myeloproliferative neoplasms (MPNs). , Special guest ... discuss his family's cancer journey at the reception. ...
(Date:11/26/2014)... /PRNewswrie/ -- Theravalues Corporation annuncia con orgoglio il lancio ... di Hi Europe 2014 (dal 2 al 4 dicembre, ... della curcumina con la maggiore biodisponibilità di sempre, con ... approvati dalle norme europee. La curcumina è ... ( Curcuma longa ) che è stata associata con ...
Breaking Biology Technology:Whitehouse Laboratories Joins Morris County Chamber of Commerce 2Whitehouse Laboratories Joins Morris County Chamber of Commerce 3Pittcon Releases 2015 Mobile App 2CURE Magazine and Incyte to Honor MPN Heroes 2CURE Magazine and Incyte to Honor MPN Heroes 3CURE Magazine and Incyte to Honor MPN Heroes 4La curcumina con la maggiore biodisponibilità di sempre farà il suo debutto in Europa 2La curcumina con la maggiore biodisponibilità di sempre farà il suo debutto in Europa 3
... Dec. 6, 2010 Regeneron Pharmaceuticals, Inc. (Nasdaq: ... 2010 Deutsche Bank BioFest on Tuesday, December 14, 2010. ...  The session may be accessed through the Company,s web ...  An archived version of the presentation will be available ...
... YM BioSciences Inc. (NYSE Amex: YMI ; TSX: ... patients enrolled in the Phase I/II trial for its JAK1/JAK2 ... an oral presentation at the 52nd American Society of Hematology ... "Anemia is the most serious symptom associated with myelofibrosis, so ...
... Md., Dec. 6, 2010 Viruses have a bad ... quickly and precisely replicate itself makes it a destructive ... team of researchers at the University of Maryland,s A. ... and Natural Resources, brought together by Professor Reza Ghodssi, ...
Cached Biology Technology:YM BioSciences Reports Positive Interim Data Including Substantial Anemia Response from Phase I/II Trial of JAK1/JaK2 Inhibitor CYT387 2YM BioSciences Reports Positive Interim Data Including Substantial Anemia Response from Phase I/II Trial of JAK1/JaK2 Inhibitor CYT387 3YM BioSciences Reports Positive Interim Data Including Substantial Anemia Response from Phase I/II Trial of JAK1/JaK2 Inhibitor CYT387 4YM BioSciences Reports Positive Interim Data Including Substantial Anemia Response from Phase I/II Trial of JAK1/JaK2 Inhibitor CYT387 5YM BioSciences Reports Positive Interim Data Including Substantial Anemia Response from Phase I/II Trial of JAK1/JaK2 Inhibitor CYT387 6Bad Virus Put to Good Use: Breakthrough Batteries 2Bad Virus Put to Good Use: Breakthrough Batteries 3Bad Virus Put to Good Use: Breakthrough Batteries 4Bad Virus Put to Good Use: Breakthrough Batteries 5Bad Virus Put to Good Use: Breakthrough Batteries 6
... the most comprehensive, cost-effective solution to ... incorporated unprecedented quality into both our ... proven detection chemistries and antibodies that ... protocol. It also includes our competitively ...
Functionally tested for consistent G-banding of chromosomes....
... Cell Medium is optimized for serum-free growth ... In this protein-free medium, Sf9 cultures routinely ... cells/ml with viabilities above 95%. This medium ... color from X-gluc staining of pBACgus recombinants ...
... formuatled for the growth of insect ... cells. Grace's Insect Mediu, Unsupplemented is ... not contain lactalbumin hydrosylate, and yeastolate, ... Insect Medium, Supplemented is formulated for ...
Biology Products: